The Central Drugs Standard Control Organisation has approved Novo Nordisk's Ozempic, a groundbreaking once-a-week injection ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal ...

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

CHICAGO, IL—High-risk patients who have type 2 diabetes plus established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or both have significantly fewer major adverse ...

India’s drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type-2 ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...